VPHi submits feedback to the FDA on the draft guidance document

In collaboration with the In Silico World (ISW) and SIMCor consortia, the VPH Institute has provided feedback to FDA on the draft guidance for Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions.

This draft guidance builds on the risk-based assessment framework of the ASME (V&V40) and develops further the concept of credibility evidences for computational models. A call for feedback to the public had been launched since December 2021. The feedback letter from the two consortia have been received and made public by FDA on the 28th of March 2022 (https://www.regulations.gov/docket/FDA-2021-D-0980/comments).

The full documents can be found here:

- Comments from In Silico World

- Comments from SIMCor

Further information can be found here

Date: 13/04/2022 | Tag: | News: 1311 of 1588
All news


More news


More events

Subscribe to the VPH Institute Newsletter


Read all the newsletters of the VPH Institute